Cofactors V and VIII after endotoxin administration to human volunteers

Thrombosis Research
E G WyshockR W Colman

Abstract

Coagulation factor V (FV) and factor VIII (FVIII) are usually decreased in septicemic DIC. Low doses of endotoxin administered to healthy volunteers stimulate activation of the fibrinolytic, contact and coagulation systems, but not clinical DIC. Following the administration of endotoxin (4 ng/kg) to normal volunteers (n = 15), we applied new assays for FV antigens using monoclonal antibodies to the activation peptide (C1) and to the light chain of FV. At 5 hours, FV coagulant activity was significantly decreased (64 +/- 9%), as was the FV light chain antigen (74 +/- 6%), without a change in factor V C1 antigen or total protein C. In contrast, FVIII coagulant activity was greater than preinfusion levels at 2-5 hours. The decrease in FV activity may be due to APC cleavage of FV heavy chain, but the loss of light chain antigen suggests that plasmin and/or calpain also contribute. APC may not be the only enzyme responsible for cofactor inactivation. FV is one of the most sensitive markers, even reflecting subclinical activation of coagulation.

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J P MiletichP W Majerus
Jan 1, 1978·Journal of Immunological Methods·J W Goding
Sep 15, 1991·Annals of Internal Medicine·R C Bone
Jan 1, 1991·Chest·R L DannerJ E Parillo
Feb 6, 1990·Biochemistry·D D Monkovic, P B Tracy
Aug 1, 1989·Critical Care Medicine·J F HesselvikR Maller
Aug 3, 1989·The New England Journal of Medicine·A F SuffrediniJ E Parrillo
Feb 1, 1989·Scandinavian Journal of Clinical and Laboratory Investigation·L BaggeJ Modig
Jul 29, 1987·Biochimica Et Biophysica Acta·G M RodgersW H Kane
Mar 1, 1987·The Journal of Clinical Investigation·F B TaylorK E Blick
Apr 1, 1987·Thrombosis Research·H Vinazzer, U Pangraz
Oct 17, 1968·The New England Journal of Medicine·J J CorriganN May
Jul 1, 1982·The Journal of Clinical Investigation·P C CompC T Esmon
Oct 28, 1982·The New England Journal of Medicine·A C CarvalhoW M Zapol
Aug 1, 1983·The Journal of Clinical Investigation·H C ChiuR W Colman
Oct 1, 1983·Journal of Biological Standardization·H D HochsteinS C Rastogi
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·W R ChurchD N Fass
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P B Tracy, K G Mann
Feb 15, 1982·Thrombosis Research·R L Lundblad, H R Roberts
Apr 1, 1982·The Journal of Clinical Investigation·M B Hultin
Jan 1, 1981·Journal of Immunological Methods·P F Canellas, A E Karu
Sep 1, 1980·The Journal of Clinical Investigation·B Dahlbäck
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·B Dahlbäck, B Hildebrand
Dec 19, 1947·Science·A G WareW H Seegers

❮ Previous
Next ❯

Citations

Feb 3, 2005·The Veterinary Journal·R Mischke
Jul 10, 2003·Critical Care Clinics·Marianne Nimah, Richard J Brilli
Apr 19, 2015·Critical Care : the Official Journal of the Critical Care Forum·Satoshi Gando, Yasuhiro Otomo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2021 Meta ULC. All rights reserved